NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.860
+0.010 (0.35%)
Oct 29, 2024, 4:00 PM EDT - Market closed

NeuroBo Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
24181432869,492
Upgrade
Market Cap Growth
233.87%31.75%-58.04%-62.38%-99.09%-
Upgrade
Enterprise Value
-4-8726749,508
Upgrade
Last Close Price
2.863.705.74292.801260.002100.00
Upgrade
PE Ratio
--1.50-0.13-1.85-2.87-2.14
Upgrade
PB Ratio
1.241.070.632.2211.97772.21
Upgrade
P/FCF Ratio
-1.99-1.65-1.16-2.14-8.01-1308.70
Upgrade
P/OCF Ratio
-2.00-1.66-1.16-2.14-8.01-1348.49
Upgrade
EV/EBITDA Ratio
-0.900.48-0.64-1.67-6.00-1187.37
Upgrade
EV/EBIT Ratio
-0.900.48-0.64-1.67-5.98-1184.86
Upgrade
EV/FCF Ratio
-1.200.71-0.62-1.69-6.87-1310.97
Upgrade
Debt / Equity Ratio
0.010.01-0.000.010.01
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.00-0.01-0.02
Upgrade
Quick Ratio
2.893.762.837.602.736.68
Upgrade
Current Ratio
2.943.782.857.692.896.78
Upgrade
Return on Equity (ROE)
-117.35%-64.89%-76.85%-140.22%-304.47%-270.59%
Upgrade
Return on Assets (ROA)
-57.23%-35.26%-28.36%-68.87%-60.82%-54.85%
Upgrade
Return on Capital (ROIC)
-74.83%-51.39%-39.19%-87.06%-78.51%-62.66%
Upgrade
Earnings Yield
-106.70%-69.53%-102.60%-47.11%-34.41%-0.22%
Upgrade
FCF Yield
-82.21%-60.49%-86.04%-46.66%-12.49%-0.08%
Upgrade
Buyback Yield / Dilution
-84.99%-1476.33%-233.62%-42.70%-210.43%-22.88%
Upgrade
Total Shareholder Return
-84.99%-1476.33%-233.62%-42.70%-210.43%-22.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.